More serious but rare complications include pancreatitis, gallbladder disease, and potential thyroid C-cell tumors (observed in rodent studies, with uncertain human relevance)
Schedule your weight loss consultation today and well help you choose the right option for your goals and budget
According to information presented at a GIC board meeting Thursday, in August 2022, the GIC had 798 non-Medicare members using GLP-1 drugs for weight loss and 2,559 for diabetes, costing GIC $4.2 million
Ozempic is a stronger drug
19,28,30 Further research is needed to clarify the role of GLP-1 agonists in cognitive disorders due to variability in study designs, patient populations, and treatment regimens that may contribute to differing outcomes